Alpha Tau Medical Ltd. (DRTSW)

USD 0.17

(-13.97%)

Market Cap (In USD)

12.09 Million

Revenue (In USD)

-

Net Income (In USD)

-29.15 Million

Avg. Volume

20.76 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.21-0.3325
PE
-
EPS
-
Beta Value
0.771
ISIN
IL0011839466
CUSIP
M0740A116
CIK
1871321
Shares
70380600.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Uzi Sofer
Employee Count
-
Website
https://www.alphatau.com
Ipo Date
Details
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.